Drug: INFLIXIMAB, RECOMBINANT Injury: Neoplasm malignant Quarter: 2016Q3
Total Records: 5 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
125095303 | INFLIXIMAB, RECOMBINANT | Neoplasm malignant | JANSSEN | 0.00 | 0 | 20160808 | SE | |
125215222 | INFLIXIMAB, RECOMBINANT | Neoplasm malignant | JANSSEN | 0.00 | 0 | 20160813 | CA | |
125839011 | INFLIXIMAB, RECOMBINANT | Neoplasm malignant | JANSSEN | 0.00 | 0 | 20160722 | DK | |
127176691 | INFLIXIMAB, RECOMBINANT | Neoplasm malignant | JANSSEN | 0.00 | 0 | 20160906 | JP | |
127671752 | INFLIXIMAB, RECOMBINANT | Neoplasm malignant | JANSSEN | 0.00 | 0 | 20160927 | BE |
Total Records: 5 Number of Pages: 1